233 related articles for article (PubMed ID: 18341657)
1. Antinuclear antibodies in patients with polymorphic light eruption: a long-term follow-up study.
Tzaneva S; Volc-Platzer B; Kittler H; Hönigsmann H; Tanew A
Br J Dermatol; 2008 May; 158(5):1050-4. PubMed ID: 18341657
[TBL] [Abstract][Full Text] [Related]
2. Clinical, laboratory, phototest and phototherapy findings in polymorphic light eruptions: a retrospective study of 133 patients.
Mastalier U; Kerl H; Wolf P
Eur J Dermatol; 1998 Dec; 8(8):554-9. PubMed ID: 9889427
[TBL] [Abstract][Full Text] [Related]
3. High-titer antinuclear antibodies, anti-SSA/Ro antibodies and anti-nuclear RNP antibodies in patients with idiopathic thrombocytopenic purpura.
Kurata Y; Miyagawa S; Kosugi S; Kashiwagi H; Honda S; Mizutani H; Tomiyama Y; Kanayama Y; Matsuzawa Y
Thromb Haemost; 1994 Feb; 71(2):184-7. PubMed ID: 8191396
[TBL] [Abstract][Full Text] [Related]
4. The prevalence of antinuclear antibodies in patients with apparent polymorphic light eruption.
Murphy GM; Hawk JL
Br J Dermatol; 1991 Nov; 125(5):448-51. PubMed ID: 1751350
[TBL] [Abstract][Full Text] [Related]
5. Photosensitivity in lupus erythematosus, UV photoprovocation results compared with history of photosensitivity and clinical findings.
Hasan T; Nyberg F; Stephansson E; Puska P; Häkkinen M; Sarna S; Ros AM; Ranki A
Br J Dermatol; 1997 May; 136(5):699-705. PubMed ID: 9205502
[TBL] [Abstract][Full Text] [Related]
6. Presence of systemic autoimmune disorders in patients with autoimmune thyroid diseases.
Tektonidou MG; Anapliotou M; Vlachoyiannopoulos P; Moutsopoulos HM
Ann Rheum Dis; 2004 Sep; 63(9):1159-61. PubMed ID: 15308528
[TBL] [Abstract][Full Text] [Related]
7. [Clinical significance of antinuclear antibody in patients with idiopathic thrombocytopenic purpura].
Kurata Y; Miyagawa S; Kosugi S; Kashiwagi H; Honda S; Mizutani H; Tomiyama Y; Kanayama Y; Matsuzawa Y
Rinsho Ketsueki; 1992 Sep; 33(9):1178-82. PubMed ID: 1433939
[TBL] [Abstract][Full Text] [Related]
8. Increased titres of anti-nuclear antibodies do not predict the development of associated disease in the absence of initial suggestive signs and symptoms.
Dinser R; Braun A; Jendro MC; Engel A
Scand J Rheumatol; 2007; 36(6):448-51. PubMed ID: 18092266
[TBL] [Abstract][Full Text] [Related]
9. Prevalence and patterns of anti-nuclear antibodies in Korean children with juvenile idiopathic arthritis according to ILAR criteria.
Shin JI; Kim KH; Chun JK; Lee TJ; Kim KJ; Kim HS; Kim DS
Scand J Rheumatol; 2008; 37(5):348-51. PubMed ID: 18666025
[TBL] [Abstract][Full Text] [Related]
10. Occurrence of polymorphous light eruption in lupus erythematosus.
Nyberg F; Hasan T; Puska P; Stephansson E; Häkkinen M; Ranki A; Ros AM
Br J Dermatol; 1997 Feb; 136(2):217-21. PubMed ID: 9068735
[TBL] [Abstract][Full Text] [Related]
11. Methods of choice for diagnostic antinuclear antibody (ANA) screening: benefit of adding antigen-specific assays to immunofluorescence microscopy.
Dahle C; Skogh T; Aberg AK; Jalal A; Olcén P
J Autoimmun; 2004 May; 22(3):241-8. PubMed ID: 15041045
[TBL] [Abstract][Full Text] [Related]
12. Antinuclear antibody status and risk of death in children and adolescents.
Chou IJ; Kuo CF; See LC; Hsia SH; Yu KH; Luo SF; Wu CT; Huang JL
Scand J Rheumatol; 2011 Nov; 40(6):472-7. PubMed ID: 21958028
[TBL] [Abstract][Full Text] [Related]
13. Detection of Ro/SS-A antibodies in lupus erythematosus: what does it mean for the dermatologist?
Böckle BC; Stanarevic G; Sepp NT
J Am Acad Dermatol; 2013 Mar; 68(3):385-94. PubMed ID: 23069705
[TBL] [Abstract][Full Text] [Related]
14. [Diagnostic significance of antinuclear antibodies].
Swaak AJ
Ned Tijdschr Geneeskd; 2000 Mar; 144(13):585-9. PubMed ID: 10761543
[TBL] [Abstract][Full Text] [Related]
15. The prevalence and significance of positive antinuclear antibodies in patients with fibromyalgia syndrome: 2-4 years' follow-up.
Al-Allaf AW; Ottewell L; Pullar T
Clin Rheumatol; 2002 Nov; 21(6):472-7. PubMed ID: 12447630
[TBL] [Abstract][Full Text] [Related]
16. Clinical utility of screening for antinuclear antibodies by enzyme immunoassay--a preliminary study.
Divate S; Hardikar P; Bichile LS; Rajadhyaksha A
J Assoc Physicians India; 2004 Apr; 52():290-3. PubMed ID: 15636329
[TBL] [Abstract][Full Text] [Related]
17. The coexistence of psoriasis with lupus erythematosus and other photosensitive disorders.
Zalla MJ; Muller SA
Acta Derm Venereol Suppl (Stockh); 1996; 195():1-15. PubMed ID: 8721520
[TBL] [Abstract][Full Text] [Related]
18. Positive direct immunofluorescence and autoantibody profiles in psoriasis patients.
Janjumratsang P; Phainupong D; Chanjanakijskul S; Roongphibulsopit P
J Dermatol; 2008 Aug; 35(8):508-13. PubMed ID: 18789071
[TBL] [Abstract][Full Text] [Related]
19. Screening for autoimmune markers is unnecessary during follow-up of adults with autoimmune thrombocytopenic purpura and no autoimmune markers at onset.
Vantelon JM; Godeau B; André C; Bierling P
Thromb Haemost; 2000 Jan; 83(1):42-5. PubMed ID: 10669152
[TBL] [Abstract][Full Text] [Related]
20. Antinuclear antibodies in recurrent idiopathic pericarditis: prevalence and clinical significance.
Imazio M; Brucato A; Doria A; Brambilla G; Ghirardello A; Romito A; Natale G; Palmieri G; Trinchero R; Adler Y
Int J Cardiol; 2009 Aug; 136(3):289-93. PubMed ID: 18674829
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
